Audit of unplanned admissions in neuromuscular patients: a collaborative audit by Korkodilos, M et al.
Unplanned  
admissions of  
neuromuscular patients
Audit, Information and Analysis Unit
Undertaken in conjunction with:
s	 London	SCG
s	 East	of	England	SCG
s	 South	East	Coast	SCG
s	 South	Central	SCG
s	 Queen	Square	NMD	Centre
On behalf of:
East	of	England,	London	and	South	East	Coast		
Specialised	Commissioning	Groups
a collaborative audit
June 2012
auDit,	iNforMatioN	aND	aNaLySiS	uNit2
Dr Marilena Korkodilos 
Public	Health	Director,	London	Specialised	Commissioning	Group	(SCG)
Dr Steve Hajioff 
independent	Public	Health	Consultant
Carrie Gardner 
audit,	information	and	analysis	unit,	London	SCG
Sean Overett 
assistant	Director,	London	SCG
Sarah Ibrahim 
audit,	information	and	analysis	unit,	London	SCG
Dr Fatima Jaffer 
Neuromuscular	Clinical	fellow,	MrC	Centre	for	Neuromuscular	Diseases
Professor Michael Hanna 
Consultant	Neurologist	and	Director,	MrC	Centre	for	Neuromuscular	Diseases
Authors
Commissioning sponsor
Sean	overett	
assistant	Director	
London	Specialised		
Commissioning	Group
tel:	020	8433	6856	
Email:	sean.overett@	
londonscg.nhs.uk
Clinical lead
Professor	Michael	Hanna	
Consultant	Neurologist	
National	Hospital	for	Neurology	
and	Neurosurgery
tel:	020	3448	8014	
Email:	m.hanna@ion.ucl.ac.uk
	
Project co-ordinator
Carrie	Gardner	
the	audit,	information		
and	analysis	unit	(aiau)
tel:	020	7869	8422	
Email:	carrie.gardner@	
londonscg.nhs.uk
Correspondence to:
London 
Specialised Commissioning Group
East of England 
 Specialised Commissioning Group
South East Coast 
 Specialised Commissioning Group
South Central 
 Specialised Commissioning Group
auDit	of	uNPLaNNED	aDMiSSioNS	of	NEuroMuSCuLar	PatiENtS 3
Authors Acknowledgements
the	authors	would	like	to	thank	all	those	that	participated	in	this	audit	particularly	the	staff	at	
participating	trusts	who	arranged	access	to	patient	notes.	the	authors	are	particularly	grateful	to	
Patricia	turner,	Executive	assistant	to	Professor	Hanna	who	coordinated	the	participating	trusts.
The authors would also like to acknowledge the contributions of the following people:
teresa	Moss,	Director,	National	Specialised	Commissioning	team
Sue	McLellen,	Chief	operating	officer,	London	Specialised	Commissioning	Group
Jo	Pope,	Senior	Project	Manager	&	Commissioner,	London	SCG
Carolyn	young,	associate	Director	of	Specialised	Commissioning	-	acute,	Midlands	and	East	SCG
Mike	Lander,	Senior	Commissioning	Manager,	South	of	England	SCG
theresa	Warr,	Senior	Commissioning	Manager,	South	of	England	SCG
The core neuromuscular disease expert team who developed the audit criteria:
•		MRC Centre for Neuromuscular Diseases at UCL & UCLH 
	 Professor	Mary	M	reilly
	 Dr	Hadi	Manji
	 Dr	Michael	Lunn
	 Dr	ros	Quinliven
	 Dr	Christopher	turner
	 Dr	Matthew	Parton
•	Great Ormond Street Hospital for Children NHS Foundation Trust
	 Professor	francesco	Muntoni
	 Dr	Stephanie	robb
	 Dr	adnan	Manzur
Clinicians at participating Trusts:
Dr	aleksandar	radunovic,	Barts	Health	NHS	trust
Dr	roma	Saha,	Brighton	and	Sussex	university	Hospitals	NHS	trust	
Dr	Charlotte	Brierley,	Cambridge	university	Hospitals	NHS	foundation	trust
Dr	Elizabeth	Wraige,	Guy’s	and	St	thomas’	NHS	foundation	trust
Dr	Paul	Jarman,	Homerton	university	Hospital	NHS	foundation	trust
Dr	Wojtek	rakowicz,	imperial	College	Healthcare	NHS	trust
Dr	fiona	Norwood,	King’s	College	Hospital	NHS	foundation	trust
Dr	Mike	rose,	King’s	College	Hospital	NHS	foundation	trust
Dr	Catherine	Mummery,	the	North	West	London	Hospitals	NHS	trust	
Dr	David	Hilton-Jones,	oxford	university	Hospitals	NHS	trust
Professor	Lionel	Ginsberg,	royal	free	London	NHS	foundation	trust
Dr	richard	orrel,	royal	free	London	NHS	foundation	trust
Dr	tony	Schapira,	royal	free	London	NHS	foundation	trust
Dr	Simon	Hammans,	university	Hospital	Southampton	NHS	foundation	trust
Dr	Matthew	Parton,	Whipps	Cross	university	Hospital	NHS	trust
auDit,	iNforMatioN	aND	aNaLySiS	uNit4
Contents
Executive Summary 6
1 Introduction 9
1.1.	 Background	 9
1.2.	 aims	 9
2 Methods 10
2.1.	 timescales	 10
2.2.	 Participation	 11
3 Cases audited 12
4 Individual patient level findings 13
4.1.	 Patient	demographics	 13
4.2.	 Patient	known	to	a	neuromuscular	service	 13
4.3.	 Pre-existing	neuromuscular	condition	 14
4.3.1.	 Previous	admissions	 15
5 Unplanned admissions  
during the audit period 16
5.1.	 Number	of	admissions	per	patient	 16
5.2.	 Was	the	final	diagnosis	potentially		
secondary	to	neuromuscular	condition	 16
5.3.	 Was	the	admission	preventable?	 17
5.4.	 Preventable	and	non-preventable		
admissions	by	hospital	type	 18
5.5.	 admission	characteristics	 19
5.5.1.	 admission	route	 19
5.5.2.	 admitting	specialty	 19
5.5.3.	 Coded	discharge	diagnosis	for		
the	admission	 20
5.5.4.	 Emergency	plan	 21
5.5.5.	 Neurology	review	 21
5.6.	 Length	of	stay	and	discharge	 21
5.6.1.	 Preventable	admissions	 21
5.6.2.	 Hospitals	with	and	without	a	specialist		
neuromuscular	service	 22
5.6.3.	 admission	to	an	intensive	care	unit	 22
5.6.4.	 Delayed	discharge	 22
5.6.5.	 Discharge	location	 23
5.7.	 Specialist	follow	up	 23
5.7.1.	 Specialist	neuromuscular	services	 23
5.7.2.	 other	specialist	services	 24
6 Unplanned or emergency  
admissions in children 25
6.1.	 individual	patient	data	 25
6.2.	 admissions	during	the	audit	period	 25
6.2.1.	 Was	the	admission	preventable?	 25
6.2.2.	 Neurology	review	 26
6.2.3.	 Length	of	stay	 26
6.2.4.	 admission	to	intensive	Care	unit	 26
6.2.5.	 Discharge	 26
7 Discussion 27
7.1.	 Methodology	 27
7.2.	 Preventable	and	non-preventable		
admissions	 27
7.3.	 access	to	other	services	 28
7.4.	 Delayed	discharge	 28
7.5.	 Conclusion	 28
8 Recommendations 29
9 Next Steps 30
10 References 31
Appendix 1
List of all Trusts invited to participate 32
Appendix 2
List of associated outreach hospitals 33
auDit	of	uNPLaNNED	aDMiSSioNS	of	NEuroMuSCuLar	PatiENtS 5
Table 1 Number	of	admissions	included	in	the	audit	by	NHS	trust	and	site	 12
Table 2 Known	neuromuscular	condition	 14
Table 3 Number	of	admissions	per	patient	 16
Table 4 Preventability	of	admission,	all	admissions	vs.	admissions	related	to	known	
	 neuromuscular	condition	 17
Table 5 Measures	which	could	prevent	unplanned	or	emergency	admissions	 17
Table 6 reasons	why	unplanned	or	emergency	admissions	were	not	preventable	 18
Table 7 admissions	by	hospitals	with	and	without	a	specialist	neuromuscular	service	 18
Table 8 admission	routes	 19
Table 9 admitting	specialty	 19
Table 10 iCD-10	code	and	descriptor	for	admissions	 20
Table 11 Grade	of	staff	member	who	carried	out	neurology	review	 21
Table 12 reasons	for	delayed	discharge	 22
Table 13 Delayed	discharge	by	preventable	and	non-preventable	admissions	 23
Table 14 Discharge	location	 23
Table 15 Known	neuromuscular	condition	for	paediatric	admissions	 25
Table 16 Measures	which	could	prevent	unplanned	or	emergency	admissions	 25
Table 17  reasons	why	unplanned	or	emergency	admissions	were	not	preventable	 26
Figure 1 age	distribution	of	audit	population	 12
Figure 2	 Length	of	stay	 21
Figure 3	 Patient	linked	in	with	specialist	neuromuscular	services	for	follow	up	 23
Figure 4	 Patient	linked	in	with	other	specialised	services	for	follow	up	 24
	
Tables and figures
auDit,	iNforMatioN	aND	aNaLySiS	uNit6
introduction
Neuromuscular	diseases	are	a	heterogenous	group	of	
over	60	rare	conditions,	which	affect	the	muscles	or	their	
control.	Neuromuscular	conditions	can	be	genetic	or	
acquired,	are	prevalent	in	all	ethnicities	and	range	widely	
in	severity.	Most	are	progressive	in	nature,	often	leading	
to	muscle	weakness	and	disability;	for	most	there	are	
no	effective	treatments	or	cures.	Most	neuromuscular	
disease	services	are	commissioned	by	regional	Specialised	
Commissioning	Groups	(SCGs);	the	National	Specialised	
Commissioning	team	commissions	a	small	number	on	a	
national	basis.	there	are	a	number	of	specialist	centres	
for	treating	patients	with	neuromuscular	diseases	in	
England	and	services	are	also	provided	at	different	levels	
at	other	hospitals	and	in	community	settings.	
unplanned	or	emergency	admissions	are	felt	to	be	
a	significant	problem	nationally	for	patients	with	
neuromuscular	conditions,	adversely	affecting	the	
quality	and	experience	of	care	received	by	the	patient,	
impacting	detrimentally	on	the	patient’s	health,	leading	
to	an	increased	length	of	stay	and	unnecessary	costs	to	
the	NHS.	
Executive summary
aims
an	audit	to	review	unplanned/emergency	admissions	
of	adults	and	children	with	neuromuscular	diseases	
in	the	London,	East	of	England,	South	East	Coast	and	
South	Central	regions	was	developed	to	understand	the	
reasons	for	the	unplanned	admissions,	whether	these	
admissions	were	preventable	and	if	so	the	nature	of	the	
intervention	required.
Methodology
this	was	a	retrospective	case	note	audit	of	admissions	of	
adults	and	children	with	neuromuscular	diseases	in	the	
London,	East	of	England,	South	East	Coast	and	South	
Central	regions	for	the	30	month	period	between	the	
1st	January	2009	and	the	30th	June	2011.	
an	audit	tool	for	data	collection	was	designed,	
piloted	and	validated		by	the	Neuromuscular	Clinical	
fellow	and	the	audit,	information	and	analysis	unit	
project	coordinator	with	input	from	clinicians	and	
commissioners.	the	key	audit	question	was	whether	or	
not	the	admission	was	preventable	but	other	areas	of	
interest	were	length	of	stay,	whether	or	not	the	patient	
was	known	to	a	neuromuscular	service	and	had	an	
emergency	admission	plan	and,	once	treated,	whether	
there	was	a	delay	in	discharge.
	in	the	absence	of	national	standards,	consensus	criteria	
for	a	potentially	preventable	admission	were	developed	
by	the	Clinical	Lead	in	conjunction	with	an	expert	group	
of	neuromuscular	disease	consultants	at	the	Medical	
research	Council	(MrC)	Centre	for	Neuromuscular	
Diseases.	
of	the	trusts	who	were	invited,	12	agreed	to	participate	
in	this	study	and	provided	access	to	patient	notes	to	the	
Clinical	fellow.
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results
•	in	total	395	patients	were	identified	as	having	
an	unplanned	or	emergency	admission;	data	were	
collected	on	576	separate	admissions	of	these	patients	
during	the	audit	timeframe.
Patient demographics
•	More	men	(54.4%,	215/395)	were	admitted	
than	women.
•	the	audit	population	ranged	from	birth	to	96	years	
with	a	median	age	of	61	years.	
•	Most	patients	(65.1%,	257/395)	were	White.
•	only	16.2%	(64/395)	patients	were	known	to	a	
neuromuscular	service	at	the	first	admission.	Seven		
of	these	patients	had	an	emergency	plan.
•	of	patients	with	a	known	neuromuscular	condition,	
the	most	common	condition	was	a	neuromuscular	
junction	disorder	(21.5%,	55/256).
•	Just	over	a	third	of	patients	had	other	admissions	
in	the	year	prior	to	the	data	collection	period.
Unplanned admissions during the audit period
•	Most	admissions	(65.3%,	376/576)	were	to	a	hospital	
with	a	neuromuscular	service.
•	three	quarters	of	patients	had	one	admission,	
18	patients	(4.6%,	18/395)	had	four	or	more	
admissions	in	the	audit	period.
•	of	the	total	admissions,	most	(56.8%,	327/576)	could	
not	be	prevented.	this	was	in	contrast	to	admissions	
related	to	a		known	neuromuscular	condition	where	
most	of	these	admissions	(68.7%,	156/227)	could	or	
could	possibly	have	been	prevented.
•	of	the	524	measures	that	were	identified	that	could	
have	prevented	an	admission,	most	of	these	(60.1%,	
315/524)	were	through	patient	surveillance,	access	to	
neuromuscular	services	and	having	an	emergency	plan.
•	Most	admissions	were	not	preventable	due	to	first	
presentation	of	symptoms	(33.9%,	111/327),	acute	
presentation	(29.4%,	96/327)	and	the	patient	required	
inpatient	management	(23.5%,	77/327).
•	there	were	no	marked	differences	in	preventability	
in	patients	who	were	admitted	to	a	hospital	with	a	
specialist	neuromuscular	service	(40.5%,	152/376)	
compared	to	those	who	were	admitted	to	a	hospital	
without	a	specialist	service	(45.7%,	92/200).
•	Most	admissions	(59.5%,	343/576)	were	via	the	
accident	and	Emergency	department.
•	over	half	of	admissions	(53.1%,	306/576)	were	under	
the	care	of	General	Medicine.
•	No	documented	neurology	review	took	place	for	most	
admissions	(58.3%,	336/576).	in	the	193	admissions	
where	a	neurology	review	took	place,	most	(88.1%,	
107/193)	were	carried	out	by	a	Consultant.
•	Length	of	stay	ranged	from	one	to	340	days,	with	
a	median	length	of	stay	of	six	days.	there	was	little	
difference	in	the	length	of	stay	between	the	cohort	of	
admissions	that	were	considered	preventable	(median	
length	of	stay	6.5	days)	and	those	that	were	not	
(median	length	of	stay	6	days).	
•	Eleven	percent	of	admissions	included	an	admission	
to	the	intensive	Care	unit	(iCu).	Length	of	stay	ranged	
from	one	to	166	days	with	a	median	of	7	days.
•	Eighteen	percent	of	patients	were	considered	to	have	
a	delayed	discharge	most	commonly	due	to	a	delay	in	
accessing	investigations	or	a	clinical	opinion	(41.9%,	
44/132).
•	for	most	admissions	(77.1%,	444/576)	the	patient	was	
discharged	home.
•	after	12.5%	(72/576)	of	admissions	the	patient	
was	linked	in	with	specialist	neuromuscular	services		
for	follow	up.	for	20.5%	(118/576)	of	admissions	this	
was	not	appropriate	as	the	reason	for	admission	was	
not	linked	to	a	neuromuscular	condition	or	the	patient	
had	died.
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Conclusions
this	study	has	described	the	experiences	of	a	sample	
of	patients	with	a	neuromuscular	condition	and	has	
found	that	over	a	third	of	admissions	in	this	sample	
were	preventable	and	a	further	5%	were	‘possibly’	
preventable.	this	not	only	places	potentially	unnecessary	
stress	on	patients	and	their	families	but	also	represents	a	
significant	opportunity	cost	to	the	NHS.	
the	study	has	also	highlighted	measures	which	could	
potentially	prevent	such	admissions	and	commissioners	
should	work	with	neurology	and	neuromuscular	
services	to	develop	integrated	referral	and	management	
pathways	to	ensure	that	all	patients	with	neuromuscular	
conditions	have	access	to	the	right	care	at	the	right	time	
whether	that	is	in	a	specialist	centre,	local	hospital	or	in	
the	community.
recommendations
1 Monitoring	of	known	neuromuscular	patients	and	
access	to	neuromuscular	services	between	clinic	
appointments	should	be	strengthened.	this	could	be	
co-ordinated	in	a	more	formal	process	by	the	service,	
for	example	by	the	clinical	nurse	specialist.
2	 the	specialist	neuromuscular	centre	should	co-
ordinate	care	across	different	sub-specialities	
(neuromuscular,	cardiac	and	respiratory).	
fragmentation	of	care	across	different	hospitals	
should	be	avoided,	where	possible,	to	ensure	good	
communication,	avoid	conflicting	advice	and	provide	
an	integrated	care	pathway.
3	 all	patients	with	a	known	neuromuscular	diagnosis	
should	have	a	documented	emergency	plan	which	
specifies	a	clear	point	of	access	for	emergency	care.	
this	may	include	telephone	access	for	the	patient	to	
the	specialist	neuromuscular	centre	during	times	of	
worsening	health.
Executive summary
4	 Specialist	neuromuscular	centres	should	develop	
links,	preferably	with	outreach,	with	local	hospitals	to	
enable	advice,	diagnosis	and	referral	to	be	managed	
in	a	timely	fashion.	Links	should	also	be	improved	
with	local	social	services	to	ensure	a	patient’s	ongoing	
needs	can	be	met	and	prevent	delays	in	discharge	
due	to	social	issues.
5	 Specialist	neuromuscular	centres	and	commissioners	
should	consider	together	whether	other	models	
of	care	or	network	arrangements	would	be	an	
appropriate	way	to	coordinate	care	for	these	patients.
6	 Consideration	should	be	given	to	undertaking	further	
study	of	unplanned	or	emergency	admissions	(outside	
of	London	and	outside	of	specialist	neuromuscular	
centres)	to	try	and	gain	an	understanding	of	the	
broader	neuromuscular	population.
7 all	patients	with	a	known	neuromuscular	condition	
should	have	a:
a	 Documented	referral	to	the	neurology	team	even	
if	the	neuromuscular	condition	is	not	the	prime	
reason	for	admission
b	 Emergency	plan	on	discharge
Health	professionals	should	ensure	that	there	is	clear	
documentation	of	any	review	of	a	patient.
Next	steps
•	 the	findings	of	this	study	will	be	presented	to:
–	 all	Party	Parliamentary	Group	for	Muscular	
Dystrophy
–	 Pan-Specialised	Commissioning	Group	
Neuromuscular	Working	Group	to	take	the	
recommendations	forward
–	 British	Myology	Society	annual	Meeting
•	 this	study	will	be	used	to	inform	the	development	
of	a	neuromuscular	service	specification	and	tools	to	
support	the	commissioning	of	neuromuscular	services	
by	the	Neurosciences	Clinical	reference	Group.
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1.1		Background	
Neuromuscular	diseases	are	a	heterogenous	group	of	
over	60	rare	conditions,	which	affect	the	muscles	or	their	
control.	there	is	a	lack	of	epidemiological	research	in	this	
area	and	patient	numbers	for	each	condition	or	group	
of	conditions	vary	widely,	but	data	from	the	Muscular	
Dystrophy	Campaign	suggest	that	over	70,000	people	
in	the	uK	are	living	with	a	neuromuscular	condition1.	
Neuromuscular	conditions	can	be	genetic	or	acquired,	
are	prevalent	in	all	ethnicities	and	range	widely	in	
severity.	Most	are	progressive	in	nature,	often	leading	
to	muscle	weakness	and	disability;	for	most	there	are	
no	effective	treatments	or	cures.	recent	improvements	
in	quality	of	life	and	increases	in	life	expectancy	are	due	
to	advances	in	care	and	clinical	management	not	novel	
therapies1,2.
Most	neuromuscular	disease	services	are	commissioned	
by	regional	Specialised	Commissioning	Groups	
(SCG);	the	National	Specialised	Commissioning	team	
commissions	a	small	number	on	a	national	basis.		
there	are	a	number	of	specialist	centres	for	treating	
patients	with	neuromuscular	diseases	in	England	and	
services	are	also	provided	at	different	levels	at	other	
hospitals	and	in	community	settings.	the	all	Party	
Parliamentary	Group	(aPPG)	for	Muscular	Dystrophy	
and	the	Muscular	Dystrophy	Campaign	had	become	
concerned	about	access	to	specialist	neuromuscular	
care	and	the	reliance	of	the	specialist	centres	on	
charitable	funding	and	their	Lead	Clinicians	which	it	
felt	left	them	vulnerable.	a	parliamentary	inquiry	was	
launched	in	2008	and	culminated	in	Access to Specialist 
Neuromuscular Care: The Walton Report2,	which	
shone	a	spotlight	on	current	provision	and	called	for	
prompt	action	from	the	NHS.	
following	the	Walton	report	the	SCGs	developed	
a	national	work	programme	to	implement	its	
recommendations;	this	is	being	led	by	the	East	of	
England	SCG.	in	2011	it	was	agreed	that	unplanned	
admissions	would	be	an	important	area	for	further	work.	
this	was	because	unplanned	or	emergency	admissions	
were	felt	to	be	a	significant	problem	nationally	for	
patients	with	neuromuscular	conditions,	adversely	
affecting	the	quality	and	experience	of	care	received	
by	the	patient,	impacting	detrimentally	on	the	patient’s	
health,	leading	to	an	increased	length	of	stay,	to	a	
deterioration	in	the	patient’s	condition	that	necessitated	
the	admission	and	incurring	significant	and	unnecessary	
Introduction
costs	to	the	NHS	(estimated	at	over	£28	million	in	
the	London,	East	of	England,	South	East	Coast	and	
South	Central	regions3).	it	was	thought	that	focused	
interventions	and	investment	to	ensure	all	neuromuscular	
patients	are	connected	to	a	specified	neuromuscular	
service	and	therefore	receive	expert	monitoring	and	
care	and	for	an	identified	subset	of	appropriate	patients	
having	an	agreed	emergency	plan	in	place	to	deal	with	
emergencies	in	a	planned	and	effective	manner	could	
potentially	improve	the	patient	experience,	reduce	the	
negative	impact	on	the	patient’s	health	and	mitigate		
the	costs	to	the	NHS.
an	audit	to	review	unplanned/emergency	admissions		
of	adults	and	children	with	neuromuscular	diseases	
in	the	London,	East	of	England,	South	East	Coast	and	
South	Central	regions	was	developed.	an	unplanned	
admission	is	an	admission	that	is	not	predicted	and	
happens	at	short	notice	because	of	perceived	clinical	
need4.	an	initial	scoping	exercise	was	carried	out	
and	demonstrated	that	approximately	£9	million	of	
unplanned	activity	took	place	in	2009/10	for	London	
residents.	further	information	was	required	to	
understand	the	reasons	for	the	unplanned	admissions,	
whether	these	admissions	were	preventable	and	if	so		
the	nature	of	the	intervention	required.		
1.2		aims
this	study	set	out	to:	
•	identify	unplanned	or	emergency	admissions	among	
patients	with	neuromuscular	disease	in	London,	East	of	
England,	South	East	Coast	and	South	Central	regions.
•	Determine	which	admissions	were	related	to	a	patient’s	
neuromuscular	condition	and	of	these,	which	were	
likely	to	have	been	preventable,	the	reasons	behind	
this	and	to	understand	what	measures,	if	any,	may	
have	prevented	these	admissions.
•	understand	the	proportion	of	patients	in	the	sample	
who	were	known	to	a	neuromuscular	service	and	the	
proportion	with	emergency	plans	in	place.
•	Gather	information	on	admissions	such	as	length	of	
stay	and	reasons	for	delays	in	discharge.
•	Compare	the	characteristics	of	unplanned	admissions	
at	hospitals	with	a	specialist	neuromuscular	service	and	
those	without	such	a	service.		
1
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this	was	a	retrospective	case	note	audit	of	admissions	of	
adults	and	children	with	neuromuscular	diseases	in	the	
London,	East	of	England,	South	East	Coast	and	South	
Central	regions	for	the	30	month	period	between	the	
1st	January	2009	and	the	30th	June	2011.	
Patients	were	identified	by	the	information	teams	at	
each	SCG	using	secondary	user	services	(SuS)	data	to	
identify	admissions	with	an	unplanned	admission	code	
and	a	neuromuscular	iCD-10	code	in	either	the	primary	
or	secondary	diagnosis	field.		
a	project	team	was	organised	that	consisted	of	the	lead	
clinician,	two	senior	commissioners	from	the	London	
SCG,	the	aiau	project	coordinator	and	a	Neuromuscular	
Clinical	fellow	who	was	seconded	to	the	project	to	
review	the	case	notes	and	carry	out	the	data	collection.	
an	audit	tool	for	data	collection	was	designed,	piloted	
and	validated	by	the	Neuromuscular	Clinical	fellow	and	
the	aiau	project	coordinator	with	input	from	clinicians	
and	commissioners.	the	key	audit	question	was	whether	
or	not	the	admission	was	preventable	but	other	areas	of	
interest	were	length	of	stay,	whether	or	not	the	patient	
was	known	to	a	neuromuscular	service	and	had	an	
emergency	admission	plan	and,	once	treated,	whether	
there	was	a	delay	in	discharge.
in	the	absence	of	national	standards,	consensus	criteria	
for	a	potentially	preventable	admission	were	developed	
by	the	Clinical	Lead	in	conjunction	with	an	expert	group	
of	neuromuscular	disease	consultants	at	the	MrC	Centre	
for	Neuromuscular	Diseases.	
the	criteria	against	which	an	admission	was	assessed	
as	preventable	are	listed	below.	if	one	or	more	of	
the	criteria	were	documented	to	be	present	on	case	
note	review	by	the	Neuromuscular	Clinical	fellow	the	
admission	was	considered	to	be	potentially	preventable.	
the	Clinical	fellow	visited	each	participating	site	where	
actual	case	notes	had	been	collated	in	collaboration	with	
the	local	consultant	team.	Data	obtained	directly	from	
case	note	review	were	entered	immediately	on	site	into	
the	lap-top	based	electronic	audit	tool.		Electronic	data	
on	the	encrypted	laptop	were	then	physically	transported	
to	the	data	repository	team	base	and	downloaded	
securely.	analysis	was	undertaken	by	an	independent	
data	analyst	separate	from	the	Clinical	fellow	and	team.	
all	necessary	data	protection,	audit	and	governance	
regulations	were	strictly	adhered	to.
Methods
•	Known	potentially	preventable	complication	of	
neuromuscular	disease
-	 Chest	infection
-	 falls	without	fracture/injury
-	 falls	with	fracture/injury	
-	 Cardiac	failure/arrhythmia	in	patients	with	
neuromuscular	disease	at	risk	of	cardiomyopathy
-	 respiratory	failure	in	patients	at	risk	
neuromuscular	disease
-	 other	neuromuscular	disease	specific	avoidable	
complication	eg	myasthenia	relapse
•	immunosuppression	compliance	failure
•	recognised	immunosuppression	complications
•	Evidence	of	a	previously	agreed	emergency	plan	not	
followed	documented	in	the	notes
•	Documentation	of	contact	with	a	healthcare	
professional	(in	the	week)	prior	to	the	unplanned	
admission
•	recent	recurrent	attendances	to	and	direct	discharge	
from	a&E	without	appropriate	onward	referral	to	
neurology,	neuromuscular	or	therapy	service
•	Delayed	discharge	from	hospital	from	a	recent	prior	
admission
•	Early	readmission	to	hospital	with	an	existing	or	new	
avoidable	problem	related	to	the	neuromuscular	
disorder
2.1		timescales	
Hospital	visits	for	data	collection	were	carried	out	from	
July	2011	until	January	2012.	interim	results	based	on	
data	collected	up	to	the	end	of	october	were	presented	
at	a	neuromuscular	workshop	held	by	the	East	of	
England	SCG	on	the	1st	December	2011.	
2
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Methods
2.2		Participation	
there	are	ten	NHS	trusts	with	specialist	neuromuscular	
services	in	the	East	of	England,	London,	South	
Central	and	South	East	Coast	regions	each	with	
associated	outreach	hospitals.	an	initial	search	of	SuS	
data	identified	a	number	of	other	trusts	which	had	
admissions	with	a	neuromuscular	iCD-10	code	in	either	
the	primary	or	secondary	diagnosis	field.	appendix	1	lists	
all	trusts	that	were	invited	to	participate	in	the	study	and	
appendix	2	lists	all	associated	outreach	hospitals.		
of	the	trusts	who	were	invited,	the	following	12	agreed	
to	participate	in	this	study	and	provided	access	to	patient	
notes	to	the	Clinical	research	fellow:
•	Barts	Health	NHS	trust	(royal	London	Hospital	and	
Whipps	Cross	Hospital)
•	Brighton	and	Sussex	university	Hospitals	NHS	trust
•	the	North	West	London	Hospitals	NHS	trust	(Central	
Middlesex	Hospital	and	Northwick	Park	Hospital)
•	Guy’s	and	St	thomas’	NHS	foundation	trust	
(Evelina	Children’s	Hospital)	
•	Great	ormond	Street	Hospital	for	Children	
NHS	foundation	trust
•	Homerton	university	Hospital	NHS	foundation	trust
•	imperial	College	Healthcare	NHS	trust	(Charing	Cross	
Hospital	and	Hammersmith	Hospital)	
•	oxford	university	Hospitals	NHS	trust	(John	radcliffe	
Hospital)
•	Barking,	Havering	and	redbridge	university	Hospitals	
NHS	trust	(King	George	Hospital	and	Queen’s	Hospital)
•	university	College	London	Hospitals	NHS	foundation	
trust
•	royal	free	London	NHS	foundation	trust
•	university	Hospital	Southampton	NHS	foundation	trust	
the	remaining	trusts	either	declined	to	participate	
because	of	time	or	administration	support	constraints	or	
did	not	respond	to	the	request	within	the	predetermined	
time	scale.
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Table 1 – Number of admissions included in the audit by NHS Trust and site
Trust Hospital Number of 
admissions
Barts Health NHS Trust Royal London* 22
Whipps Cross** 28
Brighton and Sussex University Hospitals  
NHS Trust
66
Barking, Havering and Redbridge University 
Hospitals NHS Trust
King George 2
Queen’s 30
The North West London Hospitals NHS Trust Central Middlesex 1
Northwick Park 57
Guy’s and St Thomas’ NHS Foundation Trust* Evelina Children’s 6
Great Ormond Street Hospital for Children NHS 
Foundation Trust*
7
Homerton University Hospital NHS  
Foundation Trust
16
Imperial College Healthcare NHS Trust* Charing Cross 36
Hammersmith 10
Oxford University Hospitals NHS Trust* John Radcliffe 103
University College London Hospitals NHS 
Foundation Trust (including NHNN)*
37
Royal Free London NHS Foundation Trust* 45
University Hospital Southampton NHS 
Foundation Trust*
110
Total 576
in	total	395	individual	patients	were	identified	as	having	had	unplanned	or	emergency	admissions	
between	the	1st	January	2009	and	30th	June	2011	and	were	included	in	the	dataset.	for	these	
patients	data	were	collected	on	576	separate	admissions	during	the	audit	time	frame	and	were	
included	in	the	analysis	for	this	report.	
Cases audited
3
*	 Denotes	trusts	considered	to	have	a	specialist	neuromuscular	service.
**	 Barts	Health	was	formed	on	1st	april	2012	so	at	the	time	of	data	collection	Whipps	Cross	
Hospital	was	not	yet	part	of	this	NHS	trust.
auDit	of	uNPLaNNED	aDMiSSioNS	of	NEuroMuSCuLar	PatiENtS 13
the	following	analysis	is	based	on	the	cohort	of	
individual	patients	rather	than	on	an	admission	by	
admission	basis.	395	individual	patients	were	found	in	
the	audit.	for	patients	with	multiple	recorded	admissions	
during	the	audit	period,	data	were	taken	from	the	first	
admission	for	which	data	were	collected.
4.1		Patient	demographics	
Gender
the	audit	population	was	54.4%	male	(n=215)	and	
45.3%	female	(n=179).	for	one	patient	no	gender		
was	recorded.
Age
the	audit	population	ranged	from	birth	to	96	years	
of	age	with	a	median	age	of	61	years.	there	were	no	
differences	between	the	male	and	female	cohorts.	
for	patients	with	multiple	admissions	during	the	audit	
period,	age	was	calculated	at	the	time	of	the	first	
admission	during	the	time	for	which	data	were	collected.
Individual patient level findings
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Figure 1 – Age distribution of audit population
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the	paediatric	cohort	(defined	for	this	study	as	children	
under	the	age	of	16)	made	up	10.4%	(n=41)	of	the	total	
population	in	the	audit	and	are	analysed	separately	in	
section	6.
Ethnicity
Sixty	five	percent	of	the	audit	population	were	identified	
as	white	(Caucasian)	(n=257),	10.6%	(n=42)	were	south	
asian,	4.3%	(n=17)	were	black	(afro-Caribbean	origin),	
one	patient	was	from	a	mixed	background	and	17.7%	
were	from	another	ethnic	background	(n=70).	for	eight	
patients	(2.0%)	ethnicity	was	not	recorded.
Patient region of residence 
Just	over	half	of	the	patients	were	from	London	(n=203,	
51.4%)	and	the	majority	of	those	were	from	Primary	
Care	trusts	(PCts)	in	north	London	(n=185,	91.1%).	
thirteen	percent	of	patients	(n=51)	were	from	the	South	
East	Coast	region	and	one	patient	was	from	the	North	
East	but	being	treated	in	London.	for	140	patients	
(35.4%)	this	information	was	not	recorded	including	
all	129	patients	who	attended	John	radcliffe	and	
Southampton	Hospitals	and	it	may	be	possible	patients	
who	attended	these	two	hospitals	were	all	from	the	
South	Central	region.
4.2		Patient	known	to	a	
neuromuscular	service	
this	question	looks	at	whether	patients	are,	or	have	
been,	under	the	ongoing	care	of	a	neuromuscular	
service.	of	the	395	individual	patients,	64	(16.2%)	were	
already	known	to	a	neuromuscular	service	at	the	first	
admission	for	which	data	were	collected,	while	over	
three	quarters	(n=304,	76.9%)	were	not.	27	patients	
(6.8%)	had	confirmed	neuromuscular	diagnoses	but	it	
was	not	clear	from	the	notes	if	they	were	known	to	a	
neuromuscular	service	or	not.
Emergency plan
of	the	individual	patients,	3.0%	(n=12)	had	a	
documented	emergency	plan	at	the	first	admission	
for	which	data	were	collected	while	the	large	majority	
(n=378,	95.7%)	did	not.	for	five	patients	this	
information	was	not	recorded.
of	the	64	patients	known	to	a	neuromuscular	service,	
seven	had	an	emergency	plan	(10.9%),	87.5%	(n=56)	
did	not	and	for	one	patient	this	information	was	not	
recorded.
Cases audited
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Individual patient level findings
Table 2 – Known neuromuscular condition
Neuromuscular condition Number of 
patients (%)
Neuromuscular junction disorder 55 (21.5)
Unspecified neuropathy 40 (15.6)
Diabetic neuropathy 31 (12.1)
Other specified neuropathy 21 (8.2)
Muscular Dystrophy 20 (7.8)
Inflammatory myositis 15 (5.8)
Myotonic disorders 13 (5.1)
Inflammatory neuropathy 12 (4.7)
Spinal Muscular Atrophy 9 (3.5)
Hereditary neuropathy 7 (2.7)
Mitochondrial myopathy 5 (1.9)
Other myopathy 5 (1.9)
Neuropathy secondary to 
connective tissue disorder
4 (1.6)
Metabolic disorder 4 (1.6)
Congenital myopathy 3 (1.2)
Myopathy secondary to 
connective tissue disorder
3 (1.2)
Unspecified myopathy 3 (1.2)
Drug induced myopathy 2 (0.8)
Other 2 (0.8)
Unclear/unknown 2 (0.8)
Total 256
Despite	having	a	known	neuromuscular	condition,		
164	patients	(64.0%)	were	not	recorded	as	being	known	
to	a	neuromuscular	service.
4.3		Pre-existing	neuromuscular	
condition	
of	the	individual	patients,	over	a	third	had	no	previously	
known	neuromuscular	condition	at	the	first	admission	
for	which	data	were	collected	(n=139,	35.2%).	of	
these,	120	had	a	diagnosis	or	a	working	diagnosis	of	
neuromuscular	disease	at	discharge	and	the	admission	
likely	constituted	a	presentation	event.	Half	of	these	
120	patients	had	a	diagnosis	or	working	diagnosis	of	
Guillain-Barre	syndrome	at	discharge	and	nine	patients	
(7.5%)	had	a	diagnosis	of	Myasthenia	Gravis.	
of	the	139	patients	with	no	known	neuromuscular	
condition	at	the	first	admission	for	which	data	were	
collected,	14	went	on	to	have	further	admissions	during	
the	audit	period.	all	of	these	patients	except	one	had	
a	known	neuromuscular	condition	at	these	subsequent	
admissions.	
in	the	remaining	cohort	of	256	patients	the	most	
common	neuromuscular	condition	was	a	neuromuscular	
junction	disorder,	mainly	Myasthenia	Gravis,	(n=55,	
21.5%)	then	unspecified	neuropathy	(n=40,	15.7%)		
and	diabetic	neuropathy	(n=31,	12.1%).
of	the	21	patients	with	a	diagnosis	of	‘other	specified	
neuropathy’,	13	were	considered	to	be	alcohol	related.
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Individual patient level findings
4.3.1 Previous admissions
Just	over	a	third	of	the	individual	patients	were	recorded	
as	having	had	other	admissions	in	the	year	prior	to	the	
data	collection	period	(n=140,	35.4%)	while	43.5%	
(n=172)	had	not.	However	for	21.0%	of	patients	(n=83)	
this	information	was	either	not	clear	from	the	notes	or	
was	not	recorded.			
of	the	patients	who	had	had	previous	admissions	
(n=140),	28	(20.0%)	did	not	have	a	known	
neuromuscular	condition	and	almost	three	quarters	
(n=103,	73.6%)	were	not	recorded	as	being	known	to		
a	neuromuscular	service.	
Individual patient level findings
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Unplanned admissions  
during the audit period 
5
in	total	data	on	576	separate	unplanned	admissions	
from	the	1st	January	2009	to	the	30th	June	2011	were	
collected	and	analysed	for	this	report.	almost	two	thirds	
of	admissions	in	this	sample	(n=376,	65.3%)	were	to	
a	hospital	with	a	specialist	neuromuscular	service	while	
just	over	a	third	(n=200,	34.7%)	were	to	a	hospital	with	
no	neuromuscular	service	(please	see	table	1	for	a	list	of	
trusts	with	a	specialist	neuromuscular	service).
the	admissions	were	not	evenly	spread	throughout	the	
audit	period;	29.3%	(n=169)	occurred	in	2009,	57.2%	
(n=330)	occurred	in	2010	and	13.4%	(n=77)	occurred	in	
the	first	six	months	of	2011.
When	making	inference	as	to	what	neuromuscular	
services	can	do	in	the	prevention	of	admissions,	
whether	or	not	the	admission	is	potentially	related	to	
neuromuscular	disease	may	be	a	factor.	for	this	reason	
several	of	the	analyses	below	were,	in	addition	to	being	
carried	out	on	the	basis	of	all	admissions,	repeated	
looking	only	at	admissions	deemed	to	be	related	to	
a	pre-existing	neuromuscular	condition.	these	data	
have	only	been	included	where	they	shed	particular	
light	or	where	they	are	markedly	different	form	the	all	
admissions	analysis.
5.1.	Number	of	admissions		
per	patient
three	quarters	of	patients	(n=296)	had	one	unplanned	
admission	during	the	audit	period	(table	3).	
Table 3 - Number of admissions per patient
Number of admissions Number of 
patients (%)
One 296 (74.9)
Two 55 (13.9)
Three 26 (6.6)
Four 11 (2.8)
Five 2 (0.5)
Six or more 5 (1.3)
Total 395
5.2.	Was	the	final	diagnosis	
potentially	secondary	to	
neuromuscular	condition
of	the	576	admissions,	227	(39.4%)	were	judged	
to	be	potentially	related	to	the	patient’s	underlying	
neuromuscular	condition,	201	(34.9%)	were	not	related	
to	the	patient’s	underlying	neuromuscular	condition.	
it	should	be	noted	that	some	admissions	were	related	
to	a	disease	process,	such	as	diabetes	or	alcohol	abuse,	
that	can	lead	to	a	neuromuscular	disease	and	were	not	
related	to	the	neuromuscular	sequelae	of	the	parent	
disease	but	rather	to	some	other	presentation.	an	
example	of	this	might	be	hypoglycaemia	in	a	patient	
with	diabetes	mellitus	who	also	happens	to	have	diabetic	
neuropathy.
the	remaining	148	admissions	did	not	have	a	
neuromuscular	diagnosis	prior	to	admission	and	cannot	
therefore	be	seen	as	related	or	unrelated	to	a	prior	
diagnosis.	one	hundred	and	twenty	(81.6%)	of	these	
admissions	had	a	diagnosis	or	a	presumptive	diagnosis	of	
neuromuscular	disease	at	discharge.
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Table 4 - Preventability of admission, all 
admissions vs. admissions related to known 
neuromuscular condition
Number of 
admissions
All 
admissions (%)
Neuromuscular 
related 
admissions (%)
Yes 216 (37.5) 143 (63.0)
Possibly 28 (4.9) 13 (5.7)
No 327 (56.8) 67 (29.5)
Could not be 
determined
5 (0.9) 4 (1.8)
Total 576 227
Table 5 - Measures which could prevent 
unplanned or emergency admissions 
Intervention / 
measure
All 
preventable 
admissions 
(%) 
Preventable 
neuromuscular 
related 
admissions (%) 
Surveillance of 
patient’s condition
139 (26.5) 114 (29.9)
Access to 
neuromuscular 
services
116 (22.1) 98 (25.7)
Having an 
emergency plan
60 (11.5) 59 (15.5)
Access to/liaison 
with other services*
41 (7.8) 13 (3.4)
Prevent delay 
in referral to a 
neurology service
32 (6.1) 11 (2.9)
Provision of 
equipment 
(including orthotics)
34 (6.5) 34 (8.9)
Prevent delay in 
initial diagnosis
29 (5.5) 8 (2.1)
Patient/parent 
education
23 (4.4) 18 (4.7)
Physiotherapy 
referral/review
22 (4.2) 16 (4.2)
Monitoring of 
repeat admissions 
for recurrent 
symptoms
15 (2.9) 4 (1.0)
Access to social 
services
6 (1.1) 1 (0.3)
Access to alcohol/
substance abuse 
services
3 (0.6) 0 (0.0)
Having a discharge 
plan
3 (0.6) 4 (1.0)
Better transition  
to adult care
1 (0.2) 1 (0.3)
Total 524 381
5.3.	Was	the	admission	
preventable?
of	the	total	admissions,	37.5%	(216)	of	admissions	were	
considered	to	be	preventable	based	on	the	audit	criteria	
and	4.9%	(n=28)	were	‘possibly’	preventable.	over	half	
were	not	considered	to	be	preventable	(n=327,	56.8%)	
and	in	five	cases	this	could	not	be	determined	from	the	
notes.	the	picture	for	admissions	related	to	a	known	
neuromuscular	condition	is	significantly	different	in	
that,	of	the	227	neuromuscular	related	admissions	143	
(63.0%)	were	judged	preventable,	5.7%	(13)	possibly	
preventable	and	29.5%	(67)	not	preventable	(table	4).
in	total	244	admissions	were	considered	to	be	
preventable	or	possibly	preventable.	table	5	summarises	
the	measures	that	could	have	prevented	the	admission,	
for	some	admissions	more	than	one	measure	could	
have	prevented	it.	there	were	524	measures	that	could	
have	prevented	all	admissions	and	381	that	could	
have	prevented	admissions	of	patients	with	known	
neuromuscular	conditions.
the	most	frequent	potential	preventative	measures	
were	surveillance	of	a	patient’s	condition,	access	to	
neuromuscular	services	and	having	an	emergency	plan	
(n=315,	60.1%).	the	reasons	for	prevention	were	similar	
in	all	preventable	admissions	and	in	those	of	patients	
with	known	neuromuscular	conditions	(table	5).	 *other	services	include	respiratory,	cardiology,	palliative	care,	oncology,	
psychiatry,	diabetes,	urology,	ophthalmology	and	care	of	the	elderly.
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Unplanned admissions during the audit period
of	the	admissions	that	were	considered	to	be	non-
preventable	(327),	the	main	reason	for	this	was	because	
it	was	the	first	presentation	of	symptoms	(n=111,	
33.9%).	other	common	reasons	were	because	it	was	
an	acute	presentation	(n=89,	27.2%)	and	because	the	
patient	required	inpatient	care	and/or	investigations	
(n=77,	23.5%)	(table	6).
Non-preventable	admissions	related	to	an	underlying	
neuromuscular	condition	are	distributed	somewhat	
differently	(table	6).
Table 6 - Reasons why unplanned or emergency 
admissions were not preventable
Reason for 
admission
All non-
preventable 
admissions 
(%)
Neuromuscular 
related non-
preventable 
admissions (%)
First presentation of 
symptoms
111 (33.9) 0 (0.0)
Acute presentation 96 (29.4) 11 (16.4)
Required inpatient 
management
77 (23.5) 33 (49.3)
Needed tests to 
exclude a diagnosis
17 (5.2) 9 (13.4)
Required 
emergency surgery/
intervention/
opinion
10 (3.1) 3 (4.5)
Failed emergency 
plan
9 (2.8) 4 (6.0)
Followed 
emergency plan
5 (1.5) 7 (10.4)
Trauma 1 (0.3) 0 (0.0)
Failed discharge 1 (0.3) 0 (0.0)
Total 327 67
Table 7 - Admissions by hospitals with and 
without a specialist neuromuscular service
Hospitals with 
a specialist 
neuromuscular 
service (%)
Hospitals 
without a 
specialist 
neuromuscular 
service (%)
Preventable 139 (37.0) 77 (38.5)
‘Possibly’ 
preventable
13 (3.5) 15 (7.5)
Not preventable 221 (58.8) 106 (53.0)
Could not be 
determined
3 (0.8) 2 (1.0)
Total 376 200
5.4.	Preventable	and	non-
preventable	admissions	by	
hospital	type	
the	admissions	were	further	broken	down	into	those	
that	were	to	a	hospital	with	a	specialist	neuromuscular	
service	(n=376)	and	those	to	hospitals	without	(n=200).	
there	were	no	marked	differences	between	the	two	
cohorts:	although	fewer	admissions	into	hospitals	
without	a	specialist	service	were	considered	to	be	
unavoidable	(53%	vs	59%	at	hospitals	with	a	specialist	
neuromuscular	service)	this	was	more	a	reflection	of	a	
greater	number	of	those	admissions	which	were	judged	
‘possibly’	preventable	(7%	vs	3%)	rather	than	a	greater	
number	of	preventable	cases	(39%	vs	37%).
it	should	be	noted	that	even	where	patients	were	
admitted	to	a	hospital	with	a	specialist	neuromuscular	
service	it	may	not	have	been	the	service	they	were	
known	to	but	may	have	been	the	most	convenient	or	
appropriate	hospital	at	the	time	of	admission.	there	
were	85	admissions	to	a	hospital	with	a	specialist	service	
where	the	patient	was	known	to	neuromuscular	services	
but	of	these	over	a	quarter	(n=23,	27.1%)	were	not	into	
the	hospital	where	the	patient	was	known.
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5.5.	admission	characteristics
5.5.1. Admission route
Most	(59.5%,	n=343)	of	admissions	were	via	accident	
and	Emergency	(a&E).	other	admission	routes	were	
direct	referrals	from	a	GP	(n=85,	14.8%)	and	transfers	
from	another	hospital	(n=72,	12.5%)	(table	8).
5.5.2. Admitting specialty
General	medicine	accounted	for	over	half	of	admissions	
(n=306,	53.1%)	but	admissions	to	other	specialties	
varied	widely.	14.9%	(n=86)	of	admissions	were	to	
neurosciences	services	and	10.9%	of	admissions	were	
to	paediatric	services	(n=63).	in	five	cases	the	admitting	
specialty	was	not	recorded	(table	9).
Table 8 - Admission routes 
Number of 
admissions 
(%)
A&E 343 (59.5)
GP 85 (14.8)
Transfer from other hospital 72 (12.5)
Clinic 54 (9.4)
Other department/specialty 10 (1.7)
Home 2 (0.3)
Other* 4 (0.7)
Not known or recorded 6 (1.1)
Total 576
Table 9 - Admitting specialty
Service
Number of 
admissions 
(%)
General Medicine 306 (53.1)
Neurosciences 86 (14.9)
	 Neurology 80
	 Neuro	intensive	care 4
	 Neuro-opthalmology 2
Paediatrics 63 (10.9)
	 Paediatrics 51
	 Paediatric	neurology 4
	 PiCu 4
	 Paediatric	HDu 2
	 Paediatric	a&E 1
	 NiCu 1
Surgery 32 (5.5)
	 General	surgery 29
	 Vascular	surgery 3
Trauma and Orthopaedics 16 (2.8)
A&E 13 (2.2)
Intensive care 9 (1.6)
Rheumatology 8 (1.4)
Cardiology 6 (1.0)
Respiratory 5 (0.9)
Care of the elderly 5 (0.9)
Oncology 4 (0.7)
Gastroenterology 3 (0.5)
Stroke 3 (0.5)
Renal 2 (0.3)
Haematology 2 (0.3)
Hepatology 1 (0.2)
Ear, Nose and Throat 1 (0.2)
Acute medicine 1 (0.2)
Gynaecology 1 (0.2)
Dermatology 1 (0.2)
Ophthalmology 1 (0.2)
Plastics 1 (0.2)
Urology 1 (0.2)
Not recorded 5 (0.9)
Total 576
	*‘other’	admission	routes	were:	two	referrals	from	private	
ophthalmologists,	one	self-referral	and	one	repatriation	from	Europe.
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5.5.3. Coded discharge diagnosis  
for the admission
all	hospital	admissions	are	coded	using	the	international	
Classification	of	Diseases	(10th	revision)	coding	system	
(iCD-10),	which	is	the	international	standard	for	hospital	
diagnostic	classification.	this	enables	the	use	of	such	
data	for	epidemiological,	clinical	and	quality	purposes	
both	nationally	and	internationally	and,	in	the	NHS	
in	England,	is	used	along	with	other	coding	systems	
to	derive	the	health	related	group	(HrG)	code	which	
determines	payment.	admissions	may	have	more	
than	one	code	depending	on	primary	and	secondary	
diagnoses	and	for	this	study	the	iCD-10	code	relating	
to	the	neuromuscular	condition	was	collected	for	
each	admission.	these	data	were	not	available	for	113	
admissions.
the	single	most	common	code	range	used	was	G62	
other	polyneuropathies	(n=114,	24.6%)	followed	by	
G70	Myasthenia	Gravis	and	other	myoneural	disorders	
(n=101,	21.8%)	(table	10).
Table 10 - ICD-10 code and descriptor for 
admissions
Code and descriptor
Number of 
admissions 
(%)
G62 Other polyneuropathies 114 (24.6)
G70 Myasthenia Gravis and other 
myoneural disorders
101 (21.8)
G61 Inflammatory 
polyneuropathy
63 (13.6)
G71 Primary disorders of muscles 57 (12.3)
G72 Other myopathies 26 (5.6)
M33 Dermatopolymyositis 26 (5.6)
G63 Polyneuropathy in diseases 
classified elsewhere
18 (3.9)
G12 Spinal muscular atrophy and 
related syndromes
15 (3.2)
M60 Myositis 15 (3.2)
G60 Hereditary and idiopathic 
neuropathy
10 (2.2)
E74 Glycogen storage disorders 7 (1.5)
G13 Systemic atrophies primary 
affecting central nervous systems 
in diseases classified elsewhere
4 (0.9)
G73 Disorders of myoneural 
junction and muscle in diseases 
classified elsewhere
4 (0.9)
M61 Calcification and 
ossification of muscle
1 (0.2)
G61 & G62 1 (0.2)
G61 & G72 1 (0.2)
Total 463
of	the	two	patients	with	two	iCD-10	descriptors,	one	had	Guillain-
Barre	Syndrome	and	an	unspecified	peripheral	neuropathy	and	the	
other	had	Guillain-Barre	Syndrome	with	unspecified	myopathy.
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5.5.4. Emergency plan
there	were	12	patients	who	had	a	documented	
emergency	plan	at	the	first	admission	during	the	audit	
period	for	which	data	were	collected	and	another	four	
patients	had	one	set	up	during	the	audit	period	to	give	a	
total	of	16	patients	with	a	documented	emergency	plan.	
in	total	these	patients	had	25	admissions	during	the	
audit	period.	the	plan	was	followed	in	19	of	these	cases	
and	for	one	admission	it	was	followed	partially.	for	two	
admissions	the	plan	was	not	followed	and	in	three	cases	
this	information	was	not	available.
5.5.5. Neurology review
No	documented	neurology	review	took	place	in	the	
majority	of	admissions	(n=336,	58.3%)	and	in	47	cases	
(8.2%)	this	was	either	not	clear	from	the	notes	or	not	
recorded.
in	the	193	admissions	where	a	neurology	review	did	take	
place	most	patients	were	seen	by	a	Consultant	(n=170,	
88.1%).
Table 11 - Grade of staff member who carried 
out neurology review
Staff member
Number of 
patients (%)
Neurology Consultant 107 (55.4)
Neuromuscular Consultant 63 (32.6)
Neurology Specialist Registrar (SpR) 19 (9.8)
Myasthenia Gravis nurse 1 (0.5)
Total 193
5.6.	Length	of	stay	and	discharge
total	length	of	stay	ranged	from	one	to	340	days	
with	a	median	length	of	stay	of	six	days.	over	half	of	
admissions	(n=312,	54.1%)	resulted	in	a	length	of	stay	
of	one	week	or	less	and	18.1%	(n=104)	lasted	one	day.	
for	11	admissions	length	of	stay	could	not	be	calculated	
as	the	date	of	discharge	was	not	recorded.	total	bed	
days	amounted	to	8,556	for	all	admissions	and	3,477	for	
admissions	related	to	a	known	neuromuscular	condition.
Figure 2 - Length of stay (n=576)
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5.6.1. Preventable admissions
admissions	that	were	considered	to	be	preventable	
(n=216)	accounted	for	3,074	bed	days	(36%	of	the	total	
bed	days)	and	included	one	admission	with	a	length	of	
stay	of	340	days	and	three	with	a	length	of	stay	of	over	
100	days.	the	median	length	of	stay	was	seven	days.	
for	four	admissions	the	length	of	stay	could	not	be	
calculated	as	the	date	of	discharge	was	not	recorded.
there	was	little	difference	in	the	lengths	of	stay	between	
the	cohort	of	admissions	which	were	considered	to	be	
preventable	and	those	which	were	not	(median	6.5	vs	6	
days)	although	the	unavoidable	admissions	had	a	slightly	
higher	percentage	of	stays	of	only	one	day	(20%	vs	17%).
it	should	be	noted	that,	of	the	total	preventable	bed	
days,	72%	(2,204)	were	among	admissions	related	to	
an	underlying	neuromuscular	condition.	in	terms	of	
preventable	admissions	numbers,	66%	are	related	to	an	
underlying	neuromuscular	condition.
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5.6.2. Hospitals with and without a 
specialist neuromuscular service
there	was	little	difference	in	lengths	of	stay	between	
hospitals	with	and	without	a	specialist	neuromuscular	
service	(median	7	vs	6	days).
5.6.3. Admission to an intensive care unit 
a	number	of	admissions	included	an	admission	to	an	
intensive	care	unit	(iCu)	(n=63,	10.9%).	Length	of	stay	
on	iCu	ranged	from	one	to	166	days	with	a	median	of	7	
days	(however	length	of	stay	was	only	available	in	41/63	
cases).
of	the	63	admissions	with	an	iCu	spell,	a	third	were	
considered	to	be	preventable	(n=20,	31.7%),	six	were	
possibly	preventable	(9.5%)	and	just	over	half	were	not	
preventable	(n=34,	54.0%).	in	three	cases	this	could	not	
be	determined	from	the	notes.	this	is	broadly	in	line	with	
the	total	admissions.	the	patient	who	had	a	length	of	
stay	in	iCu	of	166	days	was	considered	to	have	had	an	
unpreventable	admission.	
in	18	of	these	admissions	(28.6%)	the	patient	was	
known	to	a	neuromuscular	service	and	for	over	half	
(n=33,	52.3%)	the	admission	was	related	to	the	patient’s	
neuromuscular	condition.	this	is	higher	than	the	
percentage	seen	for	the	total	admissions	where	39.4%	
were	related	to	an	underlying	neuromuscular	condition.
5.6.4. Delayed discharge
factors	affecting	discharge	were	assessed	qualitatively	
on	a	case	by	case	basis.	Eighteen	percent	of	admissions	
(n=105)	were	considered	to	have	had	a	delayed	
discharge.	the	most	common	reason	for	this	was	a	delay	
in	accessing	investigations	or	a	clinical	opinion	(n=44,	
41.9%).
Table 12 - Reasons for delayed discharge
Number of 
discharges 
(%)
Access to investigations/opinion 44 (41.9)
Access to rehab/intermediate care 18 (17.1)
Social care input/package of care 17 (16.2)
Medical complications 13 (12.4) 
Accommodation/home 
equipment 
11 (10.5)
Delay in transfer to another 
hospital
10 (9.5)
Access to other allied health care 
professionals
4 (3.8)
Access to respite care 3 (2.9)
Access to physiotherapy/
occupational therapy
3 (2.9)
Access to orthotics 2 (1.9)
Access to wheelchair services 2 (1.9)
Other* 5 (4.8)
Total 132
Numbers	total	greater	than	105	as	some	patients	had	multiple	reasons	
for	their	delayed	discharge.	
*	‘other’	includes	delay	in	diagnosis;	delay	in	therapy,	patient	did	not	
feel	ready	to	leave	hospital	and	patient	unwilling	to	accept	social	care	
package.
of	these	105	admissions	with	delayed	discharge,	over	
half	(n=58,	55.2%)	were	considered	to	be	preventable	
or	possibly	preventable.
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5.6.5. Discharge location
in	the	majority	of	cases	(n=444,	77.1%)	the	patient	was	
discharged	to	their	home.	for	12	discharges	this	was	
unclear	from	the	notes	or	was	not	recorded	(table	14).
Table 14 - Discharge location
Number of 
discharges 
(%)
Home 444 (77.1)
Transfer to another hospital 49 (8.5)
Transfer back to referring 
hospital
19 (3.3)
Intermediate care 12 (2.1)
Nursing care 9 (1.5)
Back to residential care 5 (0.9)
Not applicable as patient died 26 (4.5)
Unclear or not recorded 12 (2.1)
Total 576
Table 13 - Delayed discharge by preventable and non-preventable admissions
Preventable 
admissions
Possibly 
preventable 
admissions
Non-preventable 
admissions Total
Delayed discharge (%) 52 (49.5) 6 (5.7) 47 (44.8) 105
No delayed discharge (%) 151 (35.1) 17 (4.0) 262 (60.6) 430
Not applicable as patient died (%) 8 (32) 5 (20.0) 12 (48.0) 25
Not known from notes (%) 5 (45.5) 0 (0.0) 6 (55.5) 11
5.7.	 Specialist	follow	up
total	length	of	stay	ranged	from	one	to	340	days	
with	a	median	length	of	stay	of	six	days.	over	half	of	
admissions	(n=312,	54.1%)	resulted	in	a	length	of	stay	
of	one	week	or	less	and	18.1%	(n=104)	lasted	one	day.	
for	11	admissions	length	of	stay	could	not	be	calculated	
as	the	date	of	discharge	was	not	recorded.	total	bed	
days	amounted	to	8,556	for	all	admissions	and	3,477	for	
admissions	related	to	a	known	neuromuscular	condition.
5.7.1. Specialist neuromuscular services
after	12.5%	(n=72)	of	admissions	the	patient	was	linked	
in	with	specialist	neuromuscular	services	for	follow	up	
while	after	almost	two	thirds	the	patient	was	not	(n=373,	
64.8%).	for	20.5%	of	admissions	(n=118)	this	was	not	
appropriate	as	the	reason	for	admission	was	not	linked	to	
a	neuromuscular	condition	or	the	patient	had	died	and	
in	13	admissions	(2.2%)	this	information	was	either	not	
clear	from	the	notes	or	not	recorded	(figure	3).	
Figure 3 - Patient linked in with specialist 
neuromuscular services for follow up
yes
No
Not	applicable	as	not	a	
neuromuscular	admission
373,	64.8%
118,	20.5%
72,	12.5%
13,	2.2%
*Excludes	5	admissions	where	it	could	not	be	determined		
whether	the	admission	was	preventable	or	not
auDit,	iNforMatioN	aND	aNaLySiS	uNit24
Unplanned admissions during the audit period
5.7.2. Other specialist services
after	just	under	half	of	admissions	(n=276,	47.9%)	the	
patient	was	linked	in	with	another	specialist	service	for	
follow	up	while	after	237	(41.2)	admissions	the	patient	
was	not.	for	6.6%	(n=38)	this	was	not	appropriate	as	
the	patient	was	already	linked	with	other	services,	other	
specialist	services	were	not	required	or	the	patient	had	
died	and	in	25	cases	(4.3%)	this	information	was	either	
not	clear	from	the	notes	or	not	recorded	(figure	4).	
Figure 4 - Patient linked in with other 
specialised services for follow up
yes
No
Not	applicable
Not	known
38	,	6.6%
25	,	4.3%
276,	47.9%
237,	41.2%
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of	the	total	audit	population,	10%	(n=41)	were	under	
16	years	of	age.	Data	were	collected	on	66	separate	
admissions	for	these	patients	during	the	audit	period.
6.1.	 individual	patient	data	
14	children	were	recorded	as	being	known	to	a	
neuromuscular	service	at	the	first	admission	during	the	
audit	period	for	which	data	were	collected.
Six	children	had	a	documented	emergency	plan	in	place	
at	the	first	admission	for	which	data	were	collected.	
Seventeen	did	not	have	an	emergency	plan	but	did	not	
have	a	neuromuscular	diagnosis	at	the	time	of	admission,	
while	16	did	not	have	a	plan	but	did	have	a	diagnosis.	for	
two	patients	this	information	was	not	recorded.
Eighteen	children	did	not	have	a	known	neuromuscular	
diagnosis.	for	the	remaining	23	children	the	most	
common	condition	(30.4%,	n=7)	was	Spinal	Muscular	
atrophy	(table	15).
6.2.1. Was the admission preventable?
of	the	66	total	admissions,	28.7%	(19)	of	admissions	
were	considered	to	be	preventable	based	on	the	audit	
criteria	and	7.6%	(n=5)	were	‘possibly’	preventable.	
fifty-nine	percent	(n=39)	of	admissions	were	not	
considered	to	be	preventable.	in	three	cases	it	was	not	
possible	to	assess	this	from	the	notes.
in	total	24	admissions	were	considered	to	be	preventable	
or	possibly	preventable.	Most	admissions	(58.5%,	
n=38)	could	have	been	prevented	by	better	access	to	
neuromuscular	services,	having	an	emergency	plan	and	
surveillance	of	the	patient’s	condition	(table	16).	
Unplanned or emergency  
admissions in children
6
Table 15 - Known neuromuscular condition  
for paediatric admissions
Neuromuscular condition
Number of 
patients (%)
Spinal Muscular Atrophy 7 (30.4)
Muscular Dystrophy 5 (21.7)
Mitochondrial myopathy 4 (17.4)
Metabolic disorder 3 (13.0)
Congenital myopathy 3 (13.0)
Hereditary neuropathy 1 (4.3)
Total 23
Table 16 - Measures which could prevent 
unplanned or emergency admissions 
Intervention/measure
Number of 
admissions 
Access to neuromuscular services 15 (23.1)
Having an emergency plan 15 (23.1)
Surveillance of patient’s condition 8 (12.3)
Parent education and reassurance 7 (10.8)
Access to/liaison with other services* 5 (7.7)
Monitoring of repeat admissions for 
recurrent symptoms
4 (6.2)
Provision of equipment (including 
orthotics)
3 (4.6)
Having a discharge plan 3 (4.6)
Prevent delay in referral to a 
neurology service
2 (3.1)
Prevent delay in initial diagnosis 2 (3.1)
Physiotherapy referral/review 1 (1.5)
Total 65
6.2.		admissions	during	the		
audit	period
the	majority	of	patients	had	one	admission	during	the	
audit	period	(n=28,	68.3%).	of	the	remaining	13	patients:
•	Six	patients	had	two	admissions.
•	four	patients	had	three	admissions.
•	two	patients	had	four	admissions.
•	one	patient	had	six	admissions.
*other	services	include	community	paediatric	teams,	general	paediatric	
services,	feeding/gastrointestinal	services.
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of	the	admissions	that	were	considered	to	be	non-
preventable,	the	main	reason	for	this	was	because	it	was	
the	first	presentation	of	symptoms	(30.8%,	n=12).	other	
common	reasons	were	because	the	patient	required	
inpatient	care	and/or	investigations	(25.2%,	n=10)	and	
because	the	emergency	plan	failed	(20.5%.	n=8)	(table	17).
Table 17 - Reasons why unplanned or emergency 
admissions were not preventable 
Reason for admission
Number of 
admissions 
(%)
First presentation of symptoms 12 (30.8)
Required inpatient management 10 (25.6)
Failed emergency plan 8 (20.5)
Acute presentation 6 (15.4)
Followed emergency plan 3 (7.7)
Total 39
6.2.2. Neurology review
During	16	admissions	(24.2%)	the	child	had	a	neurology	
review	and	in	43	(65.1%)	admissions	no	neurology	
review	was	carried	out	(although	one	patient	was	
discussed	over	the	phone).	for	seven	admissions	this	
information	was	not	recorded.	
Most	of	the	neurology	reviews	(68.8%,	n=11)	carried	
out	for	the	16	admissions	were	by	a	Neuromuscular	
Consultant.	the	remainder	5	reviews	were	carried	out	by	
a	Consultant	Neurologist.
6.2.3. Length of stay
Length	of	stay	ranged	from	one	day	to	190	days	with	a	
median	of	four	days.	almost	two	thirds	of	admissions	of	
the	66	admissions	(n=42,	63.6%)	resulted	in	a	length	of	
stay	of	one	week	or	less.	for	two	admissions	length	of	
stay	could	not	be	calculated	as	the	date	of	discharge	was	
not	recorded.
Paediatric	bed	days	totalled	787,	which	was	9%	of	
the	total	audit	bed	days	despite	paediatric	admissions	
making	up	11%	of	the	total	admissions.
6.2.4. Admission to Intensive Care Unit
Just	under	a	third	of	paediatric	admissions	(n=20,	
30.3%)	included	an	iCu	admission.	Length	of	stay	was	
only	available	for	nine	paediatric	admissions	and	ranged	
from	two	to	27	days.
6.2.5. Discharge
five	paediatric	admissions	(7.6%)	were	considered	to	
have	had	a	delayed	discharge.	reasons	for	delayed	
discharge	were:	awaiting	suitable	discharge	destination;	
awaiting	rehabilitation	placement;	delay	in	diagnosis;	
delay	in	contacting	metabolic	team	regarding	the	
child’s	feeding	regime;	delay	in	repatriation	to	referring	
hospital.
the	majority	of	children	(72.3%,	48/66)	were	discharged	
home,	three	(4.5%)	went	back	to	the	referring	hospital,	
eight	(12.1%)	were	transferred	to	another	hospital	and	
two	(3.0%)	went	into	intermediate	care.	three	children	
died	whilst	inpatient	(4.5%)	and	for	two	children	this	
information	was	not	recorded.
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this	study	has	enabled	the	collection	of	detailed	data	
on	a	sample	of	patients	with	neuromuscular	conditions	
experiencing	unplanned	or	emergency	admissions.	
this	will	allow	commissioners	to	better	understand	the	
needs	of	this	patient	population	and	identify	which	
interventions	may	help	to	reduce	these	admissions	and	
so	optimise	the	care	received	and	the	patient	experience.
7.1.	 Methodology	
While	this	study	has	collected	a	dataset	on	576	
admissions	for	395	individual	patients	it	is	not	clear	what	
proportion	of	the	totality	of	unplanned	or	emergency	
admissions	for	the	neuromuscular	population	in	these	
regions	and	over	the	audit	timeframe	this	sample	
represents.	However	given	that	there	are	approximately	
9,000	patients	with	a	neuromuscular	condition	in	
London	alone	it	is	likely	to	be	small.	it	was	originally	
planned	that	a	larger	number	of	hospitals	across	the	four	
regions	would	be	audited	however	only	16	participated.	
additionally,	access	to	patient	notes	at	trusts	meant	
that	the	sample	was	not	evenly	distributed	across	
participating	trusts	and	regions,	for	example	no	trusts	in	
East	of	England	participated.
anecdotal	reports	had	suggested	that	the	further	away	
from	a	neuromuscular	centre	a	patient	lived,	the	more	
fragmented	their	care.	in	particular	South	East	Coast	
SCG	had	expressed	concerns	about	the	appropriateness	
of	emergency	care	for	their	patients	with	neuromuscular	
conditions	as	well	as	the	lack	of	support	services	
such	as	non-invasive	ventilation	that	these	patients	
sometimes	require.	However,	of	the	12	trusts	that	
participated	in	the	audit,	eight	were	considered	to	
have	a	specialist	neuromuscular	service	and	almost	two	
thirds	of	admissions	(n=376)	were	to	a	specialist	centre.	
additionally	of	the	admissions	to	a	hospital	without	a	
specialist	service	28	were	part	of	a	trust	with	a	specialist	
service	on	another	site.	further,	only	three	of	the	trusts	
were	outside	of	London.	therefore	it	was	not	possible	to	
map	or	measure	the	impact	of	distance	from	a	specialist	
centre	on	care	received.	further	work	at	non-specialist	
hospitals	and/or	those	outside	of	London	could	gather	
data	over	a	broader,	more	diverse	population	and	enable	
a	more	comprehensive	picture	to	be	built.
finally,	analyses	were	restricted	to	cases	where	the	
neuromuscular	condition	was	recorded	as	a	primary	or	a	
secondary	diagnosis.	it	is	possible	that	some	cases	were	
missed	due	to	the	neuromuscular	diagnosis	being	in	a	
lower	order	diagnostic	field
However,	while	the	extent	to	which	the	results	of	this	
study	could	be	extrapolated	is	not	clear,	qualitative	
themes	have	been	identified	which	are	likely	to	be	
applicable	to	the	wider	population.	additionally	the	key	
aim	of	the	audit	was	to	determine	the	proportion	of	
admissions	in	this	sample	which	could	have	potentially	
been	prevented	and	this	was	done.
7.2.	 Preventable	and		
non-preventable	admissions
over	three	quarters	of	individual	patients	(76.9%)	
were	not	known	to	a	neuromuscular	service	at	the	first	
admission	for	which	data	were	collected	and,	in	total,	
there	were	318	admissions	(55%)	where	the	patient	
was	not	known	to	a	neuromuscular	service.	it	is	not	
clear	what	could	have	been	done	to	identify	these	
patients	at	an	earlier	stage.	that	said	given	that	two	
thirds	of	preventable	admission	resulting	from	known	
neuromuscular	disease	are	not	known	to	neuromuscular	
services,	it	may	be	that	there	is	potential	to	close	this	
gap	through	better	signposting	and	integration	of	care	
pathways.	furthermore,	a	number	of	patients	in	this	
study	presented	several	times	with	recurrent	symptoms	
and	it	would	seem	that	this	too	could	respond	well	to	
better	surveillance	and	signposting	and	integration	of	
care	pathways.
the	relatively	high	proportion	of	admissions	among	
patients	with	known	neuromuscular	conditions	who	
are	not	known	to	a	neuromuscular	service	may	suggest	
that	focussing	on	increasing	engagement	with	patients	
already	known	to	specialist	centres	may	not	be	an	
optimal	strategy.
Discussion
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Discussion
Good	communication	between	health	care	professionals	
and	with	patients	is	an	essential	part	of	care	of	these	
patients.	in	the	present	study	there	were	a	number	of	
cases	where	it	was	not	possible	to	assess	preventability	
from	the	case	notes	and	it	was	not	possible	to	identify	
whether	a	patient	had	been	reviewed	by	the	neurology	
team.	in	addition,	16.5%	of	neuromuscular	related	
admissions	may	have	been	prevented	if	the	patient	
had	an	emergency	or	discharge	plan,	highlighting	the	
importance	of	discussing	the	management	and	care	with	
patients	at	discharge.
Most	(69%)	admissions	related	to	a	known	
neuromuscular	condition	were	potentially	preventable.	
this	was	due	to	a	combination	of	factors	including	
surveillance	of	the	condition,	access	to	neuromuscular	
services	and	through	having	an	emergency	plan.	
Emergency	plans,	shown	to	be	a	key	intervention	which	
could	potentially	prevent	unplanned	admissions,	seemed	
under	provided	and	underutilised.	
for	patients	who	present	with	new	or	acute	symptoms,	
diagnostic	and	referral	pathways	could	potentially	be	
improved	by	developing	links	between	specialist	centres	
and	local	hospitals	for	advice	on	the	identification	and	
management	of	potential	patients	with	neuromuscular	
conditions.
7.3.	 access	to	other	services
for	patients	with	a	pre-existing	neuromuscular	
condition	the	cohort	was	fairly	evenly	split	between	
those	whose	diagnosis	for	the	admission	was	linked	
to	their	underlying	neuromuscular	condition	(47%)	
and	those	for	whom	it	was	not	(43%).	Whilst	
admissions	unrelated	to	known	neuromuscular	
disease	were	three	times	less	likely	to	be	preventable	
(21%	vs	63%),	nevertheless	it	is	important,	especially	
given	that	the	median	age	of	the	audit	population	
was	61,	for	patients	to	be	able	to	access	other	
specialist	and	non-specialist	services	including	
cardiology,	oncology	and	care	of	the	older	person.	
7.4.	 Delayed	discharge
Just	under	a	fifth	of	admissions	were	felt	to	have	a	
delayed	discharge	and	the	largest	single	reason	for	this	
was	ready	access	to	inpatient	investigations	and	clinical	
opinion.	Better	links	between	specialist	centres	and	
local	hospitals	could	again	possibly	help	improve	this.	
other	reasons	included	issues	around	accommodation	
and	continuing	care	packages	suggesting	the	need	for	
improved	links	with	social	care.	access	to	wheelchair	and	
orthotics	services	was	not	found	to	be	significant	reasons	
for	delayed	discharge	in	this	study,	although	such	access	
was	found	to	be	important	in	preventing	admission	in	
patients	with	known	neuromuscular	conditions.
over	half	of	the	patients	considered	to	have	a	delayed	
discharge	also	had	admissions	that	were	felt	to	be	
preventable	including	one	patient	who	had	an	inpatient	
stay	of	almost	a	year	(340	days).	it	seems	clear	that	
scarce	NHS	resources	need	to	be	used	in	more	effective	
ways	to	prevent	such	high	costs	to	the	NHS	and	also	
to	patients	with	neuromuscular	conditions	and	their	
families.
7.5.	 Conclusion
this	study	has	described	the	experiences	of	a	sample	of	
patients	with	a	neuromuscular	condition	and	has	found	
that	over	a	third	of	admissions	in	this	sample	(37.5%)	
were	preventable	and	a	further	5%	were	‘possibly’	
preventable.	this	not	only	places	potentially	unnecessary	
stress	on	patients	and	their	families	but	also	represents	a	
significant	opportunity	cost	to	the	NHS.	
the	study	has	also	highlighted	measures	which	could	
potentially	prevent	such	admissions	and	commissioners	
should	work	with	neurology	and	neuromuscular	
services	to	develop	integrated	referral	and	management	
pathways	to	ensure	that	all	patients	with	neuromuscular	
conditions	have	access	to	the	right	care	at	the	right	time	
whether	that	is	in	a	specialist	centre,	local	hospital	or	in	
the	community.
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1 Monitoring	of	known	neuromuscular	patients	and	access	to	neuromuscular	services	
between	clinic	appointments	should	be	strengthened.	this	could	be	co-ordinated	in	
a	more	formal	process	by	the	service,	for	example	by	the	clinical	nurse	specialist.
2	 the	specialist	neuromuscular	centre	should	co-ordinate	care	across	different	
sub-specialities	(neuromuscular,	cardiac	and	respiratory).	fragmentation	of	care	
across	different	hospitals	should	be	avoided,	where	possible,	to	ensure	good	
communication,	avoid	conflicting	advice	and	provide	an	integrated	care	pathway.
3	 all	patients	with	a	known	neuromuscular	diagnosis	should	have	a	documented	
emergency	plan	which	specifies	a	clear	point	of	access	for	emergency	care.	this	
may	include	telephone	access	for	the	patient	to	the	specialist	neuromuscular	centre	
during	times	of	worsening	health.
4	 Specialist	neuromuscular	centres	should	develop	links,	preferably	with	outreach,	
with	local	hospitals	to	enable	advice,	diagnosis	and	referral	to	be	managed	in	a	
timely	fashion.	Links	should	also	be	improved	with	local	social	services	to	ensure		
a	patient’s	ongoing	needs	can	be	met	and	prevent	delays	in	discharge	due	to		
social	issues.
5	 Specialist	neuromuscular	centres	and	commissioners	should	consider	together	
whether	other	models	of	care	or	network	arrangements	would	be	an	appropriate	
way	to	coordinate	care	for	these	patients.
6	 Consideration	should	be	given	to	undertaking	further	study	of	unplanned	or	
emergency	admissions	(outside	of	London	and	outside	of	specialist	neuromuscular	
centres)	to	try	and	gain	an	understanding	of	the	broader	neuromuscular	
population.
7 all	patients	with	a	known	neuromuscular	condition	should	have	a:
a	 Documented	referral	to	the	neurology	team	even	if	the	neuromuscular	condition	
is	not	the	prime	reason	for	admission
b	 Emergency	plan	on	discharge
Health	professionals	should	ensure	that	there	is	clear	documentation	of	any	review		
of	a	patient.
Recommendations
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•	the	findings	of	this	study	will	be	presented	to	the:	
-	 all	Party	Parliamentary	Group	for	Muscular	
Dystrophy	
-	 Pan-Specialised	Commissioning	Group	
Neuromuscular	Working	Group	to	take	the	
recommendations	forward
-	 British	Myology	Society	annual	Meeting
•	this	study	will	be	used	to	inform	the	development	
of	a	neuromuscular	service	specification	and	tools	to	
support	the	commissioning	of	neuromuscular	services	
by	the	Neurosciences	Clinical	reference	Group.
Next Steps
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Appendix 1: List of Trusts invited to participate
Trust Name
 Barking, Havering and Redbridge University Hospitals NHS Trust
* Barts Health NHS Trust
 Brighton and Sussex University Hospitals NHS Trust
* Cambridge University Hospitals NHS Foundation Trust
* Great Ormond Street Hospital for Children NHS Foundation Trust
* Guy’s and St Thomas’ NHS Foundation Trust
 Homerton University Hospital NHS Foundation Trust
* Imperial College Healthcare NHS Trust
* King’s College Hospital NHS Foundation Trust
 Norfolk and Norwich University Hospitals NHS Foundation Trust
 North West London Hospitals NHS Trust
* Oxford University Hospitals NHS Trust
* Royal Free London NHS Foundation Trust
* University Hospital Southampton NHS Foundation Trust
* University College London Hospitals NHS Foundation Trust
# Whipps Cross University Hospital NHS Trust
*	Denotes	a	trust	with	a	specialist	neuromuscular	service
#	Part	of	Barts	Health	NHS	trust	as	of	1st	april	2012	
auDit	of	uNPLaNNED	aDMiSSioNS	of	NEuroMuSCuLar	PatiENtS 33
Trust Name
King's College Hospital Bromley Hospital
Princess Royal University Hospital
William Harvey Hospital
Queen Elizabeth Hospital
Queen Marys Hospital
Darent Valley Hospital
Tunbridge Wells Hospital
Kent and Sussex Hospital
Kent and Canterbury Hospital
Maidstone Hospital
Lewisham Hospital
Evelina Children's Hospital Medway Maritime Hospital
Kent and Canterbury Hospital
Maidstone Hospital
Chailey Hospital
Charing Cross Hospital Ealing Hospital 
St Mary's Hospital
Hillingdon Hospital 
Royal Free Hospital Welwyn Garden City Hospital
West Hertfordshire Hospital
Addenbrooke’s Hospital West Suffolk Hospital
John Radcliffe Hospital Milton Keynes Hospital
St Richard’s Hospital, Chichester
University College London Hospital Northwick Park Hospital
Central Middlesex Hospital
Homerton University Hospital
North Middlesex Hospital
Royal London Hospital Broomfield Hospital
Basildon Hospital
Southend Hospital
Colchester Hospital
Homerton University Hospital
Appendix 2: List of associated outreach hospitals
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London Specialised Commissioning Group
16th	floor,	Portland	House
Stag	Place
London	SW1E	5rS
 
www.londonscg.nhs.uk
